1. Hong Kong Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Medicskin Holdings Ltd.

Medicskin Holdings Ltd.

HHKEX:8307
0.12
HKD
+0.00
(-1.59%)
0.00EPS
82.52MMarket Cap
Medicskin Holdings Ltd.
HKEX:8307
(Hong Kong Exchange)

Recent

price

0.12

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
HKD
0.2
0.19
0.15
0.14
0.12
0.11
0.1
0.1
0.12
0.11
0.12
0.11
0.12
0.13
Revenue per Share
0.04
0.01
0.01
0.01
0.01
-0.01
-0.01
- -
0.01
-0.01
-0.01
-0.01
- -
- -
Basic EPS, GAAP
0.06
0.01
-0.01
-0.08
0.01
- -
0.03
0.02
- -
- -
0.02
0.02
0.01
- -
Free Cash Flow per Basic Share
0.01
- -
0.02
0.04
0.05
- -
0.04
- -
0.02
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.12
0.09
0.17
0.13
0.12
0.07
0.06
0.04
0.04
0.03
0.01
0.01
0.03
Book Value per Share
0.03
0.12
0.09
0.17
0.13
0.12
0.07
0.06
0.04
0.04
0.03
0.01
0.01
0.03
Tangible Book Value per Share
333
353
400
435
480
483
486
421
397
397
397
397
397
397
Basic Weighted Avg Shares
65
67
60
62
58
51
48
42
49
46
49
45
48
50
Sales/Revenue/Turnover
40.91
23.21
29.33
31.62
31.14
-12.41
-8.24
18.31
24.13
9.19
10.94
9.17
18.44
12.12
Operating Margin (%)
2
2
2
3
4
5
10
10
10
9
9
9
7
9
Depreciation Expense
14
3
2
3
3
-5
-3
1
4
-4
-3
-3
1
-2
Net Income, GAAP
20.84
43.44
35.98
27.47
35.18
- -
- -
- -
6.24
- -
- -
- -
- -
- -
Effective Tax Rate (%)
21.12
4.99
3.92
5.1
4.38
-10.65
-6.74
2.28
7.98
-7.77
-6.2
-7.49
1.96
-3.58
Profit Margin (%)
4
43
28
24
7
46
16
8
- -
-3
-2
-6
-6
-4
Working Capital
- -
- -
- -
- -
- -
- -
6
- -
12
5
- -
9
4
2
LT Debt
10
47
38
83
61
55
30
20
14
11
8
4
5
9
Total Equity
- -
23.22
26.53
23.66
16.23
- -
- -
- -
37.34
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
9.43
5.54
5.26
3.87
- -
- -
- -
13.74
- -
- -
- -
- -
- -
Return on Capital (%)
- -
11.56
5.54
5.26
3.54
-9.24
-6.93
3.23
19.19
-22.57
-24.52
-44.6
19.87
-13.53
Return on Common Equity (%)

Capital Structure

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
ST Debt
7
- -
7
LT Borrowings
- -
- -
- -
LT Finance Leases
5
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
397
397
397
Market Capitalization
101
53
83

Working Capital

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
Total Current Assets
27
- -
25
Cash, Cash Equivalents & STI
6
- -
4
Accounts Receivable, Net
1
- -
- -
Inventories
5
- -
4
Total Current Liabilities
29
- -
29
Payables & Accruals
- -
- -
- -
ST Debt
7
- -
7
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-9.91%
-20.57%
24.58%
Free Cash Flow
717.48%
136.66%
-48.78%
Net Income, GAAP
-48.16%
-1.88%
-127.72%
Sales/Revenue/Turnover
-1.8%
3.26%
6.13%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
49
2025
- -
- -
45
2026
- -
- -
48

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.01
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Medicskin Holdings Limited (8307.HK) is an investment holding company that provides medical skin care services in Hong Kong through its two Medicskin-branded centers located in prime areas of Central and Tsim Sha Tsui; the company offers medical consultation services for diagnosing skin conditions such as acne, pigmentation, rosacea, dermatitis, eczema, and warts; prescription and dispensing services for pharmaceutical products, medicines, and skincare items; and non-invasive or minimally invasive treatment services including skin rejuvenation, facial sculpturing, body contouring, acne scar treatments, enlarged pore reduction, naevi removal, hair removal, injections of Botulinum Toxin Type A and hyaluronic acid, cauterization, thread lifting, laser therapies, radiofrequency, intense focused ultrasound, and High-Intensity Facial Electrical Stimulation; it also operates an online shop under the "facematter" brand selling professional skincare products and provides anti-aging and preventive medicine services encompassing genetics testing, hereditary risk assessments, precision cancer tests, ct-DNA early cancer screening, women's health tests, beauty and allergy tests, comprehensive health check-ups, body care, men's care, and vaccinations. Founded in 2000 and headquartered at Unit B, 9/F, Wing Hang Insurance Building, 11 Wing Kut Street, Sheung Wan, Hong Kong, the company is a subsidiary of Topline Worldwide Limited and primarily serves long-standing clients in the medical skincare sector with a focus on evidence-based, safety-oriented procedures performed by experienced registered medical practitioners. In recent developments, Medicskin introduced the "Soprano Titanium" laser treatment utilizing three wavelengths (755nm, 810nm, and 1064nm) for skin firming, elasticity enhancement, whitening, fine line reduction, and facial contour tightening during the year ended March 31, 2025; the group adopted a new share option scheme on September 27, 2024, to incentivize eligible employees; it implemented cost-saving measures, operational optimizations, and promotional campaigns such as the 10th Listing Anniversary Thankful Day amid economic challenges and competitive pressures; and anticipates favorable lease renewals for its centers and office spaces to reduce costs while pursuing strategic expansion in Hong Kong and Mainland China, enhancement of service variety, and integration of technologies like AI for personalized anti-aging and preventive care.